These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22354982)

  • 21. [The best of congenital heart disease in 2006].
    Rey C
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():103-10. PubMed ID: 17405574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial elastance for estimating right ventricular afterload in systolic heart failure.
    Amin A; Taghavi S; Esmaeilzadeh M; Bakhshandeh H; Naderi N; Maleki M
    Congest Heart Fail; 2011; 17(6):288-93. PubMed ID: 22103920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary arterial hypertension in adult patients with congenital heart disease].
    Serino G; Giacomazzi F
    Pediatr Med Chir; 2010; 32(6):274-9. PubMed ID: 21462449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of pulmonary hypertension during exercise: ready for clinical prime time?
    Maréchaux S; Ennezat PV
    Arch Cardiovasc Dis; 2011 Apr; 104(4):211-5. PubMed ID: 21624787
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of age on rehabilitation outcomes and survival in post-acute inpatient cardiac rehabilitation.
    Frengley JD; Sansone GR; Alba A; Uppal K; Kleinfeld J
    J Cardiopulm Rehabil Prev; 2011; 31(4):230-8. PubMed ID: 21317799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and therapeutic options in pediatric pulmonary hypertension.
    Tulloh R
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):361-74. PubMed ID: 16716097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heartmate II implantation with right coronary bypass grafting in ischemic cardiomyopathy with "fixed" pulmonary hypertension: treatment strategy to protect right ventricular function.
    Sommer SP; Gorski A; Aleksic I; Yildirim C; Schimmer C; Beissert M; Weininger M; Leyh RG
    J Card Surg; 2010; 25(1):116-9. PubMed ID: 19549043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.
    Borlaug BA; Melenovsky V; Russell SD; Kessler K; Pacak K; Becker LC; Kass DA
    Circulation; 2006 Nov; 114(20):2138-47. PubMed ID: 17088459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification.
    van Albada ME; Berger RM
    Cardiol Young; 2008 Feb; 18(1):10-7. PubMed ID: 18205971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Training-induced increase in nitric oxide metabolites in chronic heart failure and coronary artery disease: an extra benefit of water-based exercises?
    Laurent M; Daline T; Malika B; Fawzi O; Philippe V; Benoit D; Catherine M; Jacques R
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):215-21. PubMed ID: 19276981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Balady GJ; Williams MA; Ades PA; Bittner V; Comoss P; Foody JM; Franklin B; Sanderson B; Southard D; ; ; ; ;
    Circulation; 2007 May; 115(20):2675-82. PubMed ID: 17513578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of pulmonary arterial hypertension associated with congenital heart disease with specific pulmonary arterial hypertension vasoactive drugs combined with transcatheter closure strategy:a case report].
    Shang X; Peng T; Liu M; Zhou H; Zhang G
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):963-4. PubMed ID: 25620261
    [No Abstract]   [Full Text] [Related]  

  • 33. Importance of exercise training session duration in the rehabilitation of coronary artery disease patients.
    Hansen D; Dendale P; Berger J; Onkelinx S; Reyckers I; Hermans A; Vaes J; Reenaers V; Meeusen R
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):453-9. PubMed ID: 18677171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Special populations in cardiovascular rehabilitation. Peripheral arterial disease, non-insulin-dependent diabetes mellitus, and heart failure.
    Hiatt WR; Regensteiner JG; Wolfel EE
    Cardiol Clin; 1993 May; 11(2):309-21. PubMed ID: 8508456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study.
    Logeart D; Gueffet JP; Rouzet F; Pousset F; Chavelas C; Solal AC; Jondeau G
    Eur J Heart Fail; 2009 Jan; 11(1):53-7. PubMed ID: 19147457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The grown-up congenital cardiac patient.
    Borghi A; Ciuffreda M; Quattrociocchi M; Preda L
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):78-82. PubMed ID: 17255822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benefits and risks of physical activity in patient with coronary heart disease].
    Gohlke H
    Wien Klin Wochenschr; 1995; 107(24):760-5. PubMed ID: 8585210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who is likely to benefit from phase II cardiac rehabilitation?
    Araya-Ramírez F; Briggs KK; Bishop SR; Miller CE; Moncada-Jiménez J; Grandjean PW
    J Cardiopulm Rehabil Prev; 2010; 30(2):93-100. PubMed ID: 20216361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.